Blood serum concentration and urinary excretion of myoinositol in patients with malignant tumors
Trznadel, K.; Walasek, L.; Lutz, W.; Nagański, T.; Fajndt, S.
Polski Tygodnik Lekarski 32(46): 1785-1787
1977
ISSN/ISBN: 0032-3756 PMID: 593947 Document Number: 117834
Document emailed within 1 workday
Related Documents
Kołomecki, K.; Maciaszczyk, P.; Stepień, H.; Cywiński, J.; Cielecka, J.; Stepień, T.; Kuzdak, K. 2006: Evaluation of p53 and soluble Fas ligand (sFasL) serum level concentration as indicators of apoptosis in serum of patients with benign and malignant primary follicular thyroid tumors Endokrynologia Polska 57(4): 320-325Inoue, S.; Shibata, S.; Okumura, A.; Tanaka, T.; Onitsuka, Y.; Yoshimura, T.; Aiko, A.; Ikuta, Y.; Fukuma, K.; Matsuura, K. 1985: UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(3 Part 1): 499-504
Sazonov, V.P. 1971: Penicillin concentration in blood and sputum and dynamics of its urinary excretion in patients with chronic inflammatory diseases of the respiratory organs following intrapleural administration Antibiotiki 16(7): 664-666
Sadowski, Z.; Tubylewicz, H. 1974: Serum oxacillin concentration and urinary excretion following oral administration Polski Tygodnik Lekarski 29(9): 355-357
Miyazaki, N.; Shionoiri, H.; Uneda, S.; Yasuda, G.; Gotoh, E.; Fujishima, S.; Kaneko, Y.; Kawahara, Y.; Yamazaki, Y. 1982: Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension Nihon Jinzo Gakkai Shi 24(4): 421-428
López, J.M.; Arteaga, E.; Castro, D. 1982: Effects of nifedipine on the blood concentration and urinary excretion of electrolytes and hormones in normal subjects Revista Medica de Chile 110(4): 323-327
Nikolaenkova, V.A.; Alenina, T.V.; Sterliagova, L.I. 1991: Medium-weight molecules in the blood serum of patients with hyperplastic processes in the endometrium and benign and malignant ovarian tumors Akusherstvo i Ginekologiia 10: 56-58
Maikowski, C.; Rösch, W.; Sörgel, F. 1993: Ceftriaxone in malignant occlusive jaundice. Studies of serum and bile concentration in disordered bile excretion Fortschritte der Medizin 111(32): 513-516
Minami, M.; Togashi, H.; Sano, M.; Yoshioka, M.; Saito, I.; Morii, K.; Tochihara, M.; Hirogami, M.; Nomura, A.; Saito, H. 1985: Effects of new antihypertensive agent, 2-[4-(n-butyryl)-homopiperazine-1-ul]-4-amino-6, 7-dimethoxy-quinazoline (E-643), on blood pressure, urinary sodium excretion and urinary norepinephrine excretion rate in stroke-prone, spontaneously hypertensive rats Hokkaido Journal of Medical Science 60(4): 536-543
Kacprzyk, F. 2002: Serum level and urinary excretion of RANTES in patients with primary glomerulonephritis Polskie Archiwum Medycyny Wewnetrznej 108(3): 837-842
Krausová, Z.; Pavlík, F.; Andĕl, M.; Bartos, V.; Malý, J. 1990: Serum levels and urinary excretion of zinc in patients with insulin-dependent diabetes Casopis Lekaru Ceskych 129(30): 945-949
Kacprzyk, F. 2002: Serum level and urinary excretion of soluble Fas (sFas) in patients with primary glomerulopathies Polskie Archiwum Medycyny Wewnetrznej 108(3): 843-847
Smirne, S.; Ideo, G.; Colombo, M.; Lanzi, G.L. 1974: Serum gamma-glutamyl-transpeptidase and urinary excretion of D-glucaric acid in epileptic patients treated with anticonvulsants Rivista di Neurologia 44(4): 234-238
Vieweg, W.V.; David, J.J.; Rowe, W.T.; Peach, M.J.; Veldhuis, J.D.; Kaiser, D.L.; Spradlin, W.W. 1988: Correlation of parameters of urinary excretion with serum osmolality among patients with psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome) Psychiatric Medicine 6(1): 81-97
Kacprzyk, F. 2002: Serum levels and urinary excretion of soluble receptors for tumor necrosis factor (sTNF R) in patients with primary glomerulonephritis Polskie Archiwum Medycyny Wewnetrznej 107(3): 215-221
Shinpo, K.; Kawai, K.; Shinzato, M.; Ito, S.; Fujita, K.; Matsui, T.; Nakamura, K.; Kitagawa, Y.; Hirano, M.; Ito, M. 1984: Urinary polyamine analysis and its clinical significance. I. Analysis by HPLC and its clinical application. A. Urinary acetylpolyamine in patients with malignant tumors Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 59: 29-37
Yang, Z.L. 1993: Twenty four-hour arterial blood pressure and urinary norepinephrine excretion rate in patients with essential hypertension Zhonghua Xin Xue Guan Bing Za Zhi 21(6): 373-5 381
Varazashvili Varazi, L.M.; Osmanova, V.R.; Barkadze, K.I. 2006: Study of serum levels of magnesium in the patients with malignant tumors Georgian Medical News 136: 35-39
Kverneland, A.; Kirkegaard, B.C.; Wiesniewski, J.; Svendsen, P.A.; Deckert, T.; Nerup, J. 1986: Evaluation of blood glucose determination and 24-hour urinary glucose excretion as indicators of mean blood glucose as expressed by HbAIc in patients with insulin-dependent diabetes mellitus Ugeskrift for Laeger 148(30): 1899-1901
Pokora, J.; Berbeć, H.; Zearo, T. 1970: Blood serotonin level and 24-hour urinary excretion of 5-hydroxyindoloacetic acid in patients with gastric and duodenal ulcer before and during treatment with Spasmophen Polski Tygodnik Lekarski 25(32): 1199-1201